Altitude Group (ALT) Competitors

Altitude Group (LON:ALT) and Open Orphan (LON:ORPH) are both small-cap pharmaceutical products companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

Is ALT or ORPH more profitable?

Altitude Group has a net margin of 2.90% compared to Open Orphan's net margin of 0.00%. Altitude Group's return on equity of 6.70% beat Open Orphan's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Altitude Group	2.90%	6.70%	1.65%
Open Orphan	N/A	N/A	N/A

Do insiders & institutionals believe in ALT or ORPH?

17.4% of Altitude Group shares are owned by institutional investors. 56.5% of Altitude Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Which has better earnings and valuation, ALT or ORPH?

Altitude Group has higher earnings, but lower revenue than Open Orphan.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Altitude Group	£23.50M	0.74	£682.34K	£0.93	25.68
Open Orphan	£34.71M	0.00	N/A	N/A	N/A

Does the media favor ALT or ORPH?

In the previous week, Altitude Group's average media sentiment score of 0.99 beat Open Orphan's score of 0.00 indicating that Altitude Group is being referred to more favorably in the media.

Company	Overall Sentiment
Altitude Group	Positive
Open Orphan	Neutral

Summary

Altitude Group beats Open Orphan on 7 of the 8 factors compared between the two stocks.